These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1184208)

  • 21. Studies on the rate of incorporation of tryptophan into nicotinamide-adenine dinucleotides in rats chronically exposed to carbon disulphide.
    Wrońska-Nofer T; Obrebska M
    Biochem Pharmacol; 1976 Jun; 25(12):1427-8. PubMed ID: 7267
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of thyroid hormone on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Takanaka A; Takahashi A
    J Biochem; 1970 Nov; 68(5):613-23. PubMed ID: 5484443
    [No Abstract]   [Full Text] [Related]  

  • 23. Sex-related differences in cadmium-induced alteration of drug action in the rat.
    Schnell RC; Pence DH; Prosser TD; Miya T
    Toxicology; 1976; 6(3):277-9. PubMed ID: 996874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Animal experiments on the effect of hexobarbital decompostion on diurnal rhythm].
    Püschel K; Mätzsch T; von Mayersbach H; Müller O
    Beitr Gerichtl Med; 1978; 36():483-90. PubMed ID: 718656
    [No Abstract]   [Full Text] [Related]  

  • 25. Adaptation to the inhibitory effect of carbon monoxide inhalation on drug metabolism.
    Montgomery MR; Rubin RJ
    J Appl Physiol; 1973 Nov; 35(5):601-7. PubMed ID: 4770343
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence for the formation of a protein bound hydrodisulfide resulting from the microsomal mixed function oxidase catalyzed desulfuration of carbon disulfide.
    Catignani GL; Neal RA
    Biochem Biophys Res Commun; 1975 Jul; 65(2):629-36. PubMed ID: 238535
    [No Abstract]   [Full Text] [Related]  

  • 27. The state of NADPH-NADP + during mixed-function oxidation of hexobarbital in hemoglobin-free perfused rat liver.
    Sies H
    Chem Biol Interact; 1971 Aug; 3(4):308-9. PubMed ID: 4399906
    [No Abstract]   [Full Text] [Related]  

  • 28. Relevancy of bivalent sulphur excretion to carbon disulphide exposure in different metabolic conditions.
    Magos L
    Br J Ind Med; 1972; 29(1):90-4. PubMed ID: 5060251
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of carbon disulphide on metabolic processes in the aorta wall: study of the rate of cholesterol synthesis and the rate of influx of 14C -cholesterol from serum into the aorta wall.
    Wrońska-Nofer T; Parke M
    Int Arch Occup Environ Health; 1978 Sep; 42(1):63-8. PubMed ID: 711351
    [No Abstract]   [Full Text] [Related]  

  • 30. Structural disturbances in erythrocytes in workers exposed to carbon disulphide (CS2).
    Sidorowicz V; Budziszewska D; Murawska T; Smolik R
    Arh Hig Rada Toksikol; 1980 Jun; 31(2):125-9. PubMed ID: 7447712
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of sulphydryl reagents on the binding and mixed function oxidation of hexobarbital in rat hepatic microsomes.
    Paul H; Illing A; Netter KJ
    Xenobiotica; 1975 Jan; 5(1):1-15. PubMed ID: 239485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct effect of carbon monoxide on hexobarbital metabolism in the isolated perfused liver in the absence of hemoglobin.
    Takano T; Motohashi Y; Miyazaki Y; Okeda R
    J Toxicol Environ Health; 1985; 15(6):847-54. PubMed ID: 4057285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hexobarbital-oxidation in vivo and in vitro in rats with bile duct ligation or ANIT-cholestasis (author's transl)].
    Brachtel D; Gallenkamp H; Richter E
    Z Gastroenterol; 1977 Jun; 15(6):378-80. PubMed ID: 888487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hexobarbital metabolism by diethylnitrosamine.
    Stevenson IH; Greenwood DT
    Biochem Pharmacol; 1968 May; 17(5):842-5. PubMed ID: 4297005
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of carbon disulphide on the cardiovascular system.
    Antov G; Kazakova B; Spasovski M; Zaikov K; Parlapanova M; Pavlova S; Stefanova M
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(4):329-35. PubMed ID: 4086811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
    van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
    Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of starvation on the kinetics of drug oxidation by hepatic microsomal enzymes from male and female rats.
    Gram TE; Guarino AM; Schroeder DH; Davis DC; Reagan RL; Gillette JR
    J Pharmacol Exp Ther; 1970 Oct; 175(1):12-21. PubMed ID: 5471443
    [No Abstract]   [Full Text] [Related]  

  • 38. The incorporation of 14C-acetate into cholesterol in rats exposed to carbon disulphide.
    Wrońska-Nofer T
    Biochem Pharmacol; 1969 Apr; 18(4):925-6. PubMed ID: 5788529
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of the rate of hepatic portal vein infusion on hexobarbital pharmacokinetics in the rat.
    Joeres RP; Vermeulen NP; Breimer DD
    Pharmacology; 1988; 36(3):210-6. PubMed ID: 3368506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of allylic oxidation pathway metabolites of racemic hexobarbital in the rat.
    Van der Graaff M; Vermeulen NP; Vinks MH; Breimer DD
    Eur J Drug Metab Pharmacokinet; 1986; 11(2):107-11. PubMed ID: 3770011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.